GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alexion Pharmaceuticals, Inc. (ALXN) [hlAlert]

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead
product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.
( Total: 31 Current Stock Recommendations )
Alexion Pharmaceuticals, Inc.   (31)
Hold 23% Buy 77%
Related companies
Perrigo Company   (24)
Hold 29% Buy 71%
Valeant ...   (27)
Sell 15% Hold 26% Buy 59%
Vertex ...   (44)
Sell Hold 36% Buy 59%
Allergan Plc   (28)
Hold 29% Buy 71%
Biogen Idec Inc   (41)
Sell Hold 27% Buy 68%
Biomarin ...   (35)
Hold 37% Buy 63%
Mylan Laboratories, ...   (21)
Hold 29% Buy 71%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Salix ...   (31)
Hold 39% Buy 61%
Filter by Gains:   
  
Rating:
Buy ALXN
up 13.31 %

Rating:
Buy ALXN
up 98.14 %

Rating:
Buy ALXN
down 8.80 %

Rating:
Buy ALXN
down 9.21 %

Rating:
Buy ALXN
up 13.11 %
Alexion Pharmaceuticals, Inc. (ALXN) rated Buy by Nomura
Thursday,  May 7, 2015  10:25 AM ET

Rating:
Buy ALXN
up 13.31 %

Rating:
Buy ALXN
down 2.04 %

Rating:
Buy ALXN
up 1.09 %

Rating:
Buy ALXN
up 13.31 %

Rating:
Buy ALXN
up 98.14 %

Rating:
Buy ALXN
up 167.54 %

Rating:
Buy ALXN
up 98.14 %

Rating:
Buy ALXN
up 93.43 %

Rating:
Buy ALXN
up 13.31 %

Rating:
Buy ALXN
up 10.36 %

Your Recent Stocks
SymbolLastChange
ALXN 147.59 down  -17.92 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy